I’m sure by now many have heard about $TRCH (Torchlight) and their merger with Metamaterial Technologies - “a smart materials and photonics company” - if not, here is a thread revealing how big this merger really is.
$TRCH (1): META is actively involved in two emerging trends: EV/Lidar and 5G. META is actively working on developing transparent 5G antennas that may be integrated into various technologies and enhance 5G signal.
$TRCH (2): As EV’s continue to increase in demand, META is also working on transparent de-icing and de-fogging solutions that don’t require the use of energy, as well as LiDAR and V2V sensing and solar integration.


$TRCH (3): META is currently partnered with Samsung where they are working on developing transparent fingerprint sensors for future technologies. A Samsung partnership is huge.
$TRCH (4): Did you think that Samsung partnership was cool? Well... META also has contracts with Lockheed Martin, AIRBUS, Panasonic, SONY, Mazda, Boeing... and the list goes on.
$TRCH (5): META is looking into innovative medical applications as they are looking into developing a non-invasive Glucometer within 2-7 years. Aside from this they are also looking to have potential applications in MRI medical imaging, cancer screening, and molecular biosensors.
$TRCH (6): COVID-19 Biosensing platform technology!! META’s -in development- biosensor technology may have applications in detection on the molecular level!! With applications in the medical field and others... the value of this is pretty apparent.
$TRCH (7): It looks like META will be NASDAQ’s first ever Metamaterials company - defined on META’s website as “complex films and other materials... that can manipulate and utilize light and other forms of energy in new and often amazing ways.”
$TRCH (8): Any sale of oil assets that Torchlight holds - such as their Orogrande Basin, a 134,000 net acre oil field - will reward shareholders with something such as a special dividend due to “Legacy Value++.”
$TRCH (9): In an “example application” META addresses Solar Energy as another possible application of their research - with the possibility of flexible solar panels - and increased efficiency.
$TRCH (10): The growth has just begun... with the company objective to have 150+ patents by 2022 and forging relationships with growing companies, this is where the journey begins, let’s see where it takes us.
$TRCH (11): Remember seeing that laser danger news for airplanes a couple years ago? Guess who solved that problem... That’s right! META!
$TRCH (12): In 2018 metaAIR glasses became available to both military and aviation markets. The glasses maintain transparency while deflecting harmful laser glare.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The rumors around $CCIV and Lucid are basically confirmed now, and most know the significance of this merger. This post will not be about confirming it - I will share with you information about Lucid - so you know how big this merger is.
$CCIV (1): Lucid is an electronic vehicle company expected to have the means of rivaling Tesla - and other established automotive companies. Lucid has worked with top engineers to produce beautiful and efficient vehicles.
$CCIV (2): Lucid has racked up over a billion dollars in funding. Before going public - and if it does go public - Lucid has already received 1.2 Billion dollars in spending - $1bn+ from the Public Investment Fund of Saudi Arabia - and will continue to receive more.
Aikido PHARMA is a drug development company that partners with universities to treat illnesses - cancer and viral infections. If you have not heard about Aikido PHARMA here is a thread where I will share with you the potential of this company.
$AIKI (1): Aikido is currently has the opportunity to license two cancer treatment drugs - DHA-dFdC (Gem-DHA) licensed from the University of Texas, and Solid tumor drug (G4-1) FUNDED by Aikido and “optioned” from the University of Kentucky.
$AIKI (2): Aikido’s Gem-DHA drug has FDA approval for various cancers and they have filed a patent for an oral formulation.